drugset / Trial / NCT01656239
Dose Range Finding Study of Fedovapagon in Men With Nocturia
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine the dose level(s) of fedovapagon which result in a decrease in the mean nocturnal void frequency.
Timeline
- Start
- 2012-08
- Primary completion
- 2013-08
- Completion
- 2013-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fedovapagon | Unknown | 1 mg | Oral |
| Subject | Fedovapagon | Unknown | 2 mg | Oral |
| Subject | Fedovapagon | Unknown | 4 mg | Oral |
Indications
No indication recorded.